Immunovant had a revenue of 0.00 in the quarter ending Dec 31, 2024, with ―. This bring the company's revenue in the last twelve months to 1.50M, Decreased 0.00%. In the fiscal year ending Mar 31, 2024, Immunovant had annual revenue of 0.00 with ― growth.